21 Days to Go: Over 40 Distinguished Speakers and 400+ Confirmed Attendees for the Changping Healthcare Innovative Financial Investment Forum
In the face of changes in the external environment,
Pharmaceutical and healthcare companies seeking to gain a competitive edge,
Innovation has always been the key to success for high-quality development in enterprises and even the entire pharmaceutical and health industry.
Sci-tech innovation finance has become the most powerful driver supporting corporate development.
How will the innovation and investment landscapes of the future pharmaceutical and healthcare industry change?
How Investment Institutions and Enterprises Can Break Through in a Complex Macroeconomic Environment;
High-Quality Development of China’s Pharmaceutical and Healthcare Industry: How the Entire Industrial Chain Can Seize New Historical Opportunities;
How to promote basic research and original innovation, and accelerate the industrial application of scientific and technological achievements...
We hope to gain insights into the development of the medical and health finance industry through the 2023 Changping Medical and Health Investment Innovation Forum,
Promote the deep integration of industry and finance, empower the new track of medical infrastructure, synergize an innovative investment ecosystem, and propel China’s healthcare industry forward.
Let us meet at the 2023 Changping Medical and Health Investment Innovation Forum on November 17 at Taikang Research Institute in Changping, Beijing.
Scan the QR code to register for free
The 2023 Changping Pharmaceutical and Health Investment Innovation Forum was hosted by the People's Government of Changping District, Beijing, and jointly organized by the Future Science City Management Committee (Life Science Park Management Committee), the Management Committee of Zhongguancun Science Park Changping Park, the Financial Services Office of Changping District, Beijing, Beijing Changping Science and Technology Park Development Co., Ltd., Beijing Zhongguancun Life Science Park Development Co., Ltd., and VCBeat VB100.
As of October 27, the 2023 Changping Medical and Health Investment Innovation Forum has confirmed the attendance of 29 guests, including: Academician Zhang Xian’en, Vice Chairman of the Chinese Society for Biotechnology, Director of the Synthetic Biology Branch, and Fellow of the American Institute for Medical and Biological Engineering; Mr. Chen Youtang, Deputy Secretary-General of the Insurance Asset Management Association of China; Mr. Liu Guo’en, Dean of the Peking University Institute for Global Health Development and Member of the Academic Division of the Chinese Academy of Medical Sciences; and Mr. Xie Xin, Executive Director and Senior Vice President of Sino Biopharmaceutical Limited. The attendees include association experts from the Chinese Society for Biotechnology and the Insurance Asset Management Association of China; key leaders from the Beijing Stock Exchange; scholars and experts in healthcare from Peking University and Tsinghua University; representatives from multiple investment institutions such as LRI Jiangyuan Investment, Changkejin Investment, Chende Capital, Chuangrui Fund, Fortune Capital (Dachen Caizhi), Danlu Capital, Dianshi Chuangjian, CDH Innovations & Growth Fund, Fosun Health Capital, BGI Win-Win, Huagai Medical Early-Stage Fund, SoftBank China Capital, and Yahui Investment; representatives from listed and innovative enterprises such as Thermo Fisher Scientific, Sino Biopharmaceutical Limited, Changmugu, Hongrun Health, Saiqiao Bio, and ImmuneOnco; and representatives from incubation platforms including ATLATL, BGI Blue Rainbow Life Science Accelerator, Qiaokang Capital’s Medical Industry Facility Platform, and Yuanyi Digital Health Incubator.
Centered on the theme of “Focusing on Sci-Tech Innovation Finance to Empower New Tracks in Healthcare,” the forum will leverage Changping District’s unique industrial and financial resource advantages. It will invite venture capital partners from the healthcare ecosystem to hear insights from academic, financial, and industrial leaders driving innovation in medicine and health, exploring value investment and value creation in the future pharmaceutical and healthcare industries.
Chen Youtang | Deputy Secretary-General of the Insurance Asset Management Association of China
Zhang Xian’en | Vice Chairman of the Chinese Society for Biotechnology, Director of the Synthetic Biology Branch, Fellow of the American Institute for Medical and Biological Engineering
Liu Guoen | Dean, Institute for Global Health and Development, Peking University; Member of the Academic Division, Chinese Academy of Medical Sciences
Xie Xin | Executive Director and Senior Vice President, China Biopharmaceutical
Bi Yuanfeng | Co-founder and COO of VCBeat
Gao Jieliang | Senior Partner, CDH Innovation & Growth Fund
Kang Haihua | Senior Managing Director of Qiao Capital and CEO of the Qiao Healthcare Industry Facilities Platform
Li Fan | Fosun Global Partner, CEO of Fosun Rehabilitation Capital
Li Yang | Head of Yuanyi Digital Health Incubator
Li Jiangfeng | Partner at Fortune Capital
Liu Yu | General Manager and Managing Partner of BGI Win-Win
Shang Yuanfang | Founder and CEO of CytoNexus
Shi Huijing | Founding Partner, Yahui Investment
Tang Haofu | Partner, Chongqing Dianshi Chuangjian Fund / Shanghai Chuangrui Fund
Tao Yu | Executive General Manager of Changkejin Company
Tian Wenzhi | Chairman, CEO, and CSO of ImmuneOnco
Wang Hui | Founder of Hongrun Health Group
Xu Qian | General Manager, Beijing Office and Managing Partner, Danlu Capital
Yang Bin | Director, Center for Smart Health, Institute for Precision Medicine, Tsinghua University
Zang Dongning | Vice President, Clinical Development, Thermo Fisher Scientific China
Zhang Jiang | Founder and CEO of LRI Jiangyuan Investment
Zhang Yi | Managing Partner, Early-Stage Fund, Huagai Medical
Zhang Yiling | Chairman of Changmugu
Zhao Gang | Partner, SoftBank China Capital
Zhao Weiwen | General Manager, BGI Blue Rainbow Life Sciences Accelerator
Zheng Xiaoyu | Executive Dean of Beijing Gaobo Hospital and Beijing Gaobo Boren Hospital
Zhu Tianji | Partner, Chende Capital
Zhuang Jia | Head of Innovation Department, ATLATL; Executive Director, ATLATL Venture Capital
(The above guests are listed in order of appearance and alphabetically by name, without implying any ranking.)
Stay tuned—more guests to be confirmed...
“Answers from Innovators” launched a call for submissions targeting innovators across the pharmaceutical and healthcare sectors, formulating ten key questions based on industry development trends and proposed forum topics. This initiative aimed to uncover innovative solutions to critical challenges in industry development and investment through the collected responses. After nearly a month of solicitation, we received over 30 valid submissions, which have been carefully curated and presented in the form of posters and on-site displays.
1. Report Release
The Global Healthcare Industry Capital Report will be prominently released at the forum, with on-site interpretation by experts from VCBeat. Based on global healthcare information archived in VBInsight (VCBeat Orange Industry Think Tank), the report cleanses over 42,000 financing data entries to substantiate the changing trends of the global healthcare industry in 2023 using authentic investment and financing data, thereby helping industry practitioners gain insights into capital shifts.
2. Major Signing
Chang Development is further deepening its collaboration models with partner funds and exploring new opportunities for cooperation. A special signing ceremony has been arranged for this forum, where Chang Development will finalize on-site agreements with various partner funds. Building upon the expansion of its investment footprint, Chang Development aims to further leverage the pivotal role of investment in empowering the innovation ecosystem and accelerating industrial upgrading. Colleagues from the pharmaceutical and health industries are cordially invited to witness this signing ceremony.
As of October 27, nearly 350 professionals from the pharmaceutical and health industries had participated, with attendees coveringGovernment Agencies, Listed Companies, Innovative Enterprises, Investment Institutions, Industrial Parks, Banking Institutions, Media, Student Representativesetc. We welcome those interested in healthcare sci-tech innovation finance to sign up!
Forum Name:2023 Changping Pharmaceutical and Health Finance Investment Innovation Forum
Forum Schedule:November 17, 2023
Forum Venue:Lecture Hall, 1st Floor, Taikang Institute for Advanced Studies, Changping, Beijing
Forum Scale:300–400 people
Forum Organizing Committee:
·Organizer:
People's Government of Changping District, Beijing Municipality
·Organizer:
Future Science City Administrative Committee (Life Science Park Administrative Committee)
Changping Park Management Committee of Zhongguancun Science Park
Beijing Changping District Financial Services Office
Beijing Changping Science Park Technology Development Co., Ltd.
Beijing Zhongguancun Life Science Park Development Co., Ltd.
Beijing Egg Yolk Technology Co., Ltd. (VCBeat VB100)
Scan the QR code to register for free
Ticket Benefits:
1. Includes the report released at this forum (electronic version)
2. On-site Resource Coordination Group
3. Excerpts from Guest Speeches and Roundtable Discussions at the Forum
4. Forum Lunch
ArticleVCBeatCooperation
This forum embraces open ecosystem collaboration and cordially invites partners from the pharmaceutical, healthcare, and financial investment sectors to provide relevant support.
Sponsorship opportunities for the forum include: meal voucher advertising, bottled water advertising, inclusion of materials in attendee bags, basic booth spaces, and gift sponsorships.
For details on forum collaboration, please contact: [Changfazhan] Ms. Ma - 15911122053 (WeChat ID same as phone number)
Contact Us
Conference Inquiries: [VB100] Ms. Peng - 13364027163 (WeChat ID same as phone number)
Media Cooperation: [VB100] Ms. Zou - 15213067481 (WeChat ID same as phone number)